Agreement Preamble. Aggregate Consideration Section 1.6(c) Aggregate Consideration Per Share Section 1.6(c) beneficial owner Section 8.4(b) Book-Entry Shares Section 1.10(b) business day Section 8.4(c) Canadian Company Sale Section 6.2(d) Canadian Plan Section 2.12(a) Cash Designated Shares Section 1.9(e)(ii)(B) Cash Election Shares Section 1.9(b) Certificate of Merger Section 1.2 Certificates Section 1.10(b) Change in the Company Recommendation Section 5.3(b) Closing Section 1.2 Closing Date Section 1.2 Code Recitals Company Preamble Company 401(k) Plan Section 2.12(a) Company Benefit Plans Section 2.12(f) Company Board of Directors Section 2.4(d) Company Common Stock Recitals Company Employees Section 2.18 Company Employee Benefit Plans Section 2.12(c) Company ERISA affiliate Section 2.12(a) Company Financial Advisors Section 2.4(d) Company Material Adverse Effect Section 2.1 Company Material Contracts Section 2.21(a) Company Material Subsidiaries Section 2.1 Company Pension Plan Section 2.12(a) Company Permits Section 2.6(c) Company Preferred Stock Section 2.3 Company Recommendation Section 5.1(e) Company Reserve Reports Section 2.14(c) Company Rights Plan Section 2.3 Company Schedule Article III Company SEC Reports Section 2.7(a) Company Stockholder Approval Section 5.1(e) Company Termination Fee Section 7.3(a) Confidentiality Agreement Section 5.2(b) control Section 8.4(d) Defined Term Section or Exhibit controlled by Section 8.4(d) Debt Financing Section 5.10(a) Deemed Shares Outstanding Section 1.6(c) Delaware Law Recitals Dissenting Share Section 1.8(a) Effective Time Section 1.2 Election Deadline Section 1.9(b) Election Form Section 1.9(a) Election Form Record Date Section 1.9(a) Employment Agreement Section 4.1(f) Environmental Laws Section 2.17(a) ERISA Section 2.12(a) Exchange Act Section 2.5(b) Exchange Agent Section 1.10(a) Exchange Fund Section 1.10(a) Exchange Ratio Section 1.6(c) Expenses Section 7.3(d) Final Parent Stock Price Section 1.6(c) Funds Section 5.10(a) GAAP Section 2.1 good and defensible title Section 2.14(e) governmental authority Section 8.4(e) Hazardous Substance Section 2.17(a) HSR Act Section 2.5(b) Hydrocarbons Section 2.14(b) Indemnified Parties Section 5.4(b) Intellectual Property Section 2.20 IRS Section 2.12(a) Letter Section 3.23 Mailing Date Section 1.9(a) Merger Recitals Merger Consideration Section 1.6(a) Merger Sub Preamble NCOC 401(k) Section 2.12(a) NCOC MP Plan Section 2.12(a) Non-Election Shares Section 1.9(b) Notice of Intende...
Agreement Preamble. Assumed Option 1.4(c)(i) Book Entry Shares 2.3(c) Certificates 2.3(c) Certificate of Merger 1.1 Closing 2.1 Closing Date 2.1 Closing Date Revolving Credit Facility Preamble Code Preamble Confidentiality Agreement 7.5(h) D&O Policy 7.7(b) Delaware Secretary of State 1.1 DPA 4.23 Effective Time 1.1 Exchange Agent 2.3(a) Exchange Fund 2.3(b) FaceBank Preamble FaceBank Disclosure Letter Article IV FaceBank Fundamental Representation 2.2(c)(ii)(A) FaceBank In Licenses 4.13(e) FaceBank IP Licenses 4.13(f) FaceBank Material Contract 4.14(a) FaceBank Out Licenses 4.13(f) FaceBank Permits 4.20 FaceBank Privacy Policy 4.13(i) FaceBank Qualified Plan 4.16(b) FaceBank Real Property Leases 4.11 FaceBank Registered Intellectual Property 4.13(a) FaceBank SEC Reports 4.7 FaceBank Stock Plan 4.5(b) Annex A-10 Term Section Reference FaceBank Subsidiary Documents 4.4 FaceBank Support Shareholders Preamble fuboTV Preamble fuboTV Disclosure Letter Article III fuboTV Fundamental Representations 2.2(b)(ii)(A) fuboTV Information Statement 7.4 fuboTV In Licenses 3.12(e) fuboTV IP Licenses 3.12(f) fuboTV Material Contract 3.13(a) fuboTV Out Licenses 3.12(f) fuboTV Privacy Policy 3.12(i) fuboTV Permits 3.19 fuboTV Qualified Plan 3.15(d) fuboTV Real Property Leases 3.10 fuboTV Registered Intellectual Property 3.12(a) fuboTV Shareholder Written Consent Preamble fuboTV Stock Awards 3.5(c) fuboTV Stock Option 1.4(c)(i) fuboTV Stock Plans 3.5(b) fuboTV Subsidiary Documents 3.4 fuboTV Support Shareholders Preamble Indemnified Parties 7.7(a) Letter of Transmittal 2.3(c) Lock-Up Agreement Preamble Maximum Annual Premium 7.7(b) Merger Preamble Merger Sub Preamble Signing Date Loan Preamble Surviving Corporation 1.1 Takeover Laws 3.23 Termination Date 9.1(b)(ii) WARN Act 3.17(c) Annex A-11 EXHIBIT A FORM OF LOCK-UP AGREEMENT EXHIBIT B FUBOTV SHAREHOLDER WRITTEN CONSENT EXHIBIT C CLOSING DATE REVOLVING CREDIT FACILITY EXHIBIT D SIGNING DATE LOAN EXHIBIT E CERTIFICATE OF DESIGNATION
Agreement Preamble. Annual Royalty Cap 4.5.1(b) BBA LIBOR 1.47 Biogen Preamble Biogen Indemnitees 10.2 Claim 10.1 Clinical Collaboration Product Supply 3.3.5 Combination Product 1.53 Commercial Period 3.1 Commercial Period Milestone Event 4.4.1 Commercial Period Milestone Payment 4.4.1 Commercial Supply Agreement 3.3.6(b) “[***]” Preamble Effective Date Preamble Failure of PART B Deliverables 2.3.2(b) Field Expansion 2.5 FCPA 9.2.15 Gross Sales 1.53 Indemnified Party 10.3 Indemnifying Party 10.3 Infringement 7.2.1 Infringement Notice 7.2.1 Insolvency Event 8.2.4 NOTE: PORTIONS OF THIS EXHIBIT ARE THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST BY THE REGISTRANT TO THE SECURITIES AND EXCHANGE COMMISSION (“COMMISSION”). SUCH PORTIONS HAVE BEEN REDACTED AND FILED SEPARATELY WITH THE COMMISSION AND ARE MARKED WITH A “[***]” IN PLACE OF THE REDACTED LANGUAGE. Intec Pharma Preamble Intec Pharma Indemnitees 10.1 Intec Pharma-Owned Technology 9.2.12 License Fee 4.2 Losses 10.1 Manufacturing Know-How 3.3.7 Option 2.4.2 Option Exercise Date 2.4.2 Option Exercise Notice 2.4.2 Option Exercise Period 2.4.1 PART A Deliverables 2.3.2(a) PART B Deliverables 2.3.2(b) PART B Election Notice 2.3.2(a) Party/Parties Preamble Patent Coordinator 6.5 Phase 1 Clinical Trial Materials 2.3.2(b) Phase 1 Materials Acceptance Date 2.3.2(b) Pre-Commercialization Collaboration Notice 3.3.2 Pre-Commercialization Plan 3.3.2 Research Period 2.1 Research Period Milestone Event 4.3.1 Research Period Milestone Payment 4.3.1 Sunshine Act 9.2.15 Technology Transfer 3.3.7 Term 8.1 U.S. GAAP 1.53 UK Bribery Act 9.2.15
Agreement Preamble. As Adjusted Voting Basis 12.02 Board of Managers 1.01 Board Observers 3.02(f) Budget 2.08(a)(iv) Capital Account 12.02 Capital Contribution 12.02 CEO 4.01 CEO Manager 3.02(b)(iii Certificate 1.01 Change of Control 12.02 Code 12.02 Common Units 2.10(a) Company Preamble Company Notice 12.02 Company Refusal Period 10.03(c) Company Undersubscription Notice 10.03(e) Company’s Expiration Notice 10.03(c) Control 12.02 Convertible Securities 8.06(e)(i) Corporate Conversion 10.11(a) Covered Persons 3.10(b) Deep Track 12.02 Deep Track Board Observer 3.02(f) DGCL 5.01 Disqualification Event 2.02 Disqualified Designee 2.02 Economic Capital Account 12.02 Exchange Act 12.02 Exempted Securities 12.02 Existing Agreement Preamble Expenses 5.06(b) Fair Market Value 12.02 Fairmount Managers 3.02(b)(ii) Fairmount Members 12.02 FCPA 5.13 Fidelity Member 12.02 Fiscal Year 1.04 Fully Exercising Investors 10.03(e) Holdings 10.11(a) Holdings Reduced Equity 10.11(a) Imputed Underpayment Amount 13.01(b) 57 Incentive Units 2.10(a) Indemnified Person 5.06(a) Initial Consideration 11.03(d) Initial Equity Allocation 10.11(a) Investor Business Opportunity 3.10(b) Investor Counsel 5.11 Investor Notice Period 10.03(e) IPO 12.02 Major Investor 12.02 Manager 12.02 Mandatory Conversion Time 8.12(a) Member Preamble Member Representative 10.07(b)(vii) New Securities 12.02 Offer Notice 10.12(a) Options 8.06(e)(i) Officer 4.01 OrbiMed 12.02 Other Indemnitors 5.02 Paragon Member 12.02 Participating Preferred Member 10.04(a) Partnership Representative 3.04(h) Pass -Through Entities 9.08 Percentage Interest 12.02 Permitted Transfer 10.01(a) 58 Permitted Transferee 10.01(a) Person 12.02 Preferred Member 12.02 President 4.01 Proceeding 5.06(c) Proceeds 8.01(b) Proceeds Available for Distribution 12.02 Prohibited Transfer 10.05(c) Prohibited Transferees 10.06(c) Proposed Sale 10.07(c) Proposed Transfer 12.02 Proposed Transferee 12.02 Purchase Agreement Preamble Purchase Notice 10.03(d) Qualified IPO 8.12(a) RA Capital 12.02 Released Securities 10.13(b) Requisite Preferred Holders 12.02 Requisite Series A Preferred Holders 12.02 Requisite Series B Preferred Holders 12.02 Right of Co-Sale 12.02 Right of First Refusal 12.02 ROFR Subject 10.03(a) RTW Funds 12.02 RTW Board Observer 3.02(f) Rule 506(d) Related Party 12.02 Sale Event 11.03(a) Sale of the Company 10.07(a) Secondary Offer Notice 10.12(b) Secretary 4.01 Securities Act 2.02 Selling Holders 10.07(b) Series A Adjustment Price 12.02 Series A Adjustm...
Agreement Preamble. Antara 1.1 Business 1.1 Business Day 1.1 Certificate or Instrument 1.1 Closing 2.3(a) Closing Date 2.3(a) Company Preamble Company Certificate of Incorporation 1.1 Company Common Stock 1.1 Contract 1.1 e-mail 6.5 Encumbrance 1.1 Event 1.1
Agreement Preamble. Bankruptcy and Equity Exceptions 2.2(a) Board of Directors (or Board) 2.2(b) Company Preamble Conversion Shares 2.2(a) Convertible Note(s) 1.1 Governmental Entity 2.3(a) Investor Preamble Loan(s) 1.1 Loan Date 2.9 Loan Documents 2.2(a)
Agreement Preamble. This Agreement is negotiated pursuant to the Ohio Public Employee Collective Bargaining Act (Chapter 4117 of the Ohio Revised Code). The parties agree that there is no waiver of any of the rights granted under the Act. Where a provision of this Agreement conflicts with state law, this Agreement shall prevail. The Cleveland Metropolitan School District and the Cleveland Teachers Union jointly affirm their commitment to providing a quality education for all of Cleveland’s children. The term children includes students in both elementary and secondary grades. The Cleveland Metropolitan School District and the Cleveland Teachers Union mutually recognize that a safe and secure learning and working environment is essential to the achievement of the educational goals and objectives of the District. Accordingly, the District reaffirms its commitment to provide for the safety of students, employees, parents, and all other school community stakeholders. All stakeholders in the Cleveland Metropolitan School District shall treat one another with professionalism and respect, recognizing that the ultimate success of the District in educating Cleveland’s children requires the efforts of each and every individual.
Agreement Preamble. Aggregate Purchase Price 1.2 Amended Articles 1.1 Acquired Shares 1.2 Balance Sheet Date 2.7(a) Bankruptcy and Equity Exceptions 2.2 Closing 1.5 Closing Date 1.5 Code 2.10 Common Stock 2.4(a) Company Preamble Company Assets 2.11 Conversion Shares 2.5 Disclosure Schedule Section 2 Entity Investor 3.1 Equity Incentive Plan 2.4(d) Existing Stockholders Preamble FCPA 2.24 Financial Institution 3.11(a) Financial Statements 2.7(a) Founders Preamble GAAP 2.7(b) Governmental Entity 2.3(a) Investment Transaction Recitals Investor[s] Preamble Non-Competition Agreement 2.18(c) OFAC 3.11(a) Offering Memorandum 2.23(a) Options 2.4(e) Outstanding Plan Options 2.4(d) Per Share Price 1.2 PIIA Agreement 2.18(c) Preferred Stock 2.4(a) Purchaser Party 3.11(a) Registration Rights Agreement Recitals Securities 3.4 Securities Act 2.3(b) Series A Preferred Stock 2.4(a) Series B Preferred Stock Recitals Small Business Act 2.27 Specially Designated Nationals and Blocked Persons 3.11(a) State Secretary 5.7 Stockholders Agreement Recitals U.S. Person 3.11(a)
Agreement Preamble. Applicable Fraction Section 1.36(i)-(v) Breach Issue Recitals Commercialization Agreement Section 3.2(a) Confidential Information Section 6.2 Courts Section 11.2 Deciding Bankers Section 3.2(b) Effective Date Preamble Effective Time Section 9.5(b) First Sales Date Estimate Section 3.3 GK Statement Recitals Glucokinase Activator Section 1.11 Indemnified Party Section 8.3(a) Indemnifying Party Section 8.3(a) Infringement Claim Section 5.5 Invalidity Claim Section 5.4 Novo Preamble Novo Parties Section 8.2 Paragraph IV Claim Section 5.3(a) Partner Deadline Section 3.2(a) Product Liability Section 8.1(c)(ii)(A) Prosecution Section 5.2(a) Released Group Section 10.1 Releasing Group Section 10.1 Releasor Section 10.1 Reverting Rights Section 2.1(a) Royalty Term Section 4.2(c) Stand-by License Agreement Section 9.5(b) Term Section 9.1 Third-Party Claims Section 8.1(c) TransTech Preamble TransTech Parties Section 8.1 Umbrella Agreement Recitals
Agreement Preamble. Bankruptcy Code 3.4 Bound Party 6.1 Controlling Party 6.1 Effective Date Preamble Infinity Preamble Infinity Indemnified Parties 9.1.1 JJPRD Preamble JJPRD Indemnified Parties 9.1.2 Library Compound Exclusivity Fee 3.6.1(c) Patent Prosecution 5.1.3 Program Coordinator 2.2.1 Second Back-Up Selection Date 3.6.2 Severed Clause 9.15
